CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Secondary Offering	At-The-Market Offering	Common Stock	Common Stock Secondary Offering	Common Stock At-The-Market Offering	Additional Paid-In Capital	Additional Paid-In Capital Secondary Offering	Additional Paid-In Capital At-The-Market Offering	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2021	$ 250,967			$ 3			$ 455,210			$ (150)	$ (204,096)
Beginning Balance, Shares at Dec. 31, 2021				32,971,107
Vesting of shares of common stock subject to repurchase	6						6
Vesting of shares of common stock subject to repurchase, Shares				10,924
Issuance of common stock upon exercise of stock options	79						79
Issuance of common stock upon exercise of stock options, Shares				21,067
Share-based compensation expense	4,097						4,097
Unrealized gain (loss) on investments	(456)									(456)
Net loss	(25,987)										(25,987)
Ending Balance at Mar. 31, 2022	228,706			$ 3			459,392			(606)	(230,083)
Ending Balance, Shares at Mar. 31, 2022				33,003,098
Beginning Balance at Dec. 31, 2021	250,967			$ 3			455,210			(150)	(204,096)
Beginning Balance, Shares at Dec. 31, 2021				32,971,107
Net loss	(81,255)
Ending Balance at Sep. 30, 2022	399,264			$ 5			685,931			(1,321)	(285,351)
Ending Balance, Shares at Sep. 30, 2022				48,807,705
Beginning Balance at Mar. 31, 2022	228,706			$ 3			459,392			(606)	(230,083)
Beginning Balance, Shares at Mar. 31, 2022				33,003,098
Vesting of shares of common stock subject to repurchase	3						3
Vesting of shares of common stock subject to repurchase, Shares				2,387
Issuance of common stock upon exercise of stock options	334						334
Issuance of common stock upon exercise of stock options, Shares				88,383
Issuance of common stock, net of issuance costs		$ 215,334			$ 2			$ 215,332
Issuance of common stock, net of issuance costs, Shares					15,333,334
Share-based compensation expense	3,912						3,912
Unrealized gain (loss) on investments	(325)									(325)
Net loss	(26,923)										(26,923)
Ending Balance at Jun. 30, 2022	421,041			$ 5			678,973			(931)	(257,006)
Ending Balance, Shares at Jun. 30, 2022				48,427,202
Vesting of shares of common stock subject to repurchase	3						3
Vesting of shares of common stock subject to repurchase, Shares				1,302
Issuance of common stock upon exercise of stock options	953						953
Issuance of common stock upon exercise of stock options, Shares				265,988
Issuance of common stock, net of issuance costs			$ 1,612						$ 1,612
Issuance of common stock, net of issuance costs, Shares						113,213
Share-based compensation expense	4,390						4,390
Unrealized gain (loss) on investments	(390)									(390)
Net loss	(28,345)										(28,345)
Ending Balance at Sep. 30, 2022	399,264			$ 5			685,931			(1,321)	(285,351)
Ending Balance, Shares at Sep. 30, 2022				48,807,705
Beginning Balance at Dec. 31, 2022	372,207			$ 5			690,814			(679)	(317,933)
Beginning Balance, Shares at Dec. 31, 2022				48,877,806
Vesting of shares of common stock subject to repurchase	2						2
Vesting of shares of common stock subject to repurchase, Shares				395
Issuance of common stock upon exercise of stock options	1						1
Issuance of common stock upon exercise of stock options, Shares				253
Issuance of common stock upon vesting of restricted stock units, Shares				50,469
Share-based compensation expense	4,746						4,746
Unrealized gain (loss) on investments	505									505
Net loss	(30,815)										(30,815)
Ending Balance at Mar. 31, 2023	346,646			$ 5			695,563			(174)	(348,748)
Ending Balance, Shares at Mar. 31, 2023				48,928,923
Beginning Balance at Dec. 31, 2022	372,207			$ 5			690,814			(679)	(317,933)
Beginning Balance, Shares at Dec. 31, 2022				48,877,806
Issuance of common stock, net of issuance costs, Shares				0
Net loss	(89,747)
Ending Balance at Sep. 30, 2023	296,816			$ 5			704,900			(409)	(407,680)
Ending Balance, Shares at Sep. 30, 2023				49,068,234
Beginning Balance at Mar. 31, 2023	346,646			$ 5			695,563			(174)	(348,748)
Beginning Balance, Shares at Mar. 31, 2023				48,928,923
Vesting of shares of common stock subject to repurchase	1						1
Vesting of shares of common stock subject to repurchase, Shares				113
Issuance of common stock upon exercise of stock options	21						21
Issuance of common stock upon exercise of stock options, Shares				5,892
Issuance of common stock upon vesting of restricted stock units, Shares				28,074
Common stock issued under employee stock purchase plan	374						374
Common stock issued under employee stock purchase plan, Shares				95,232
Share-based compensation expense	4,650						4,650
Unrealized gain (loss) on investments	(427)									(427)
Net loss	(33,287)										(33,287)
Ending Balance at Jun. 30, 2023	317,978			$ 5			700,609			(601)	(382,035)
Ending Balance, Shares at Jun. 30, 2023				49,058,234
Issuance of common stock upon vesting of restricted stock units, Shares				10,000
Share-based compensation expense	4,291						4,291
Unrealized gain (loss) on investments	192									192
Net loss	(25,645)										(25,645)
Ending Balance at Sep. 30, 2023	$ 296,816			$ 5			$ 704,900			$ (409)	$ (407,680)
Ending Balance, Shares at Sep. 30, 2023				49,068,234